Chemical Structure (Dalfa 01)
Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 16729-292
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 16729-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Dalfa 02)
Figure 2 (Dalfa 03)
Principal Display Panel (10 mg Tablet carton)
Each tablet of this medication, containing Dalfampridine 10 mg, is film-coated and should not be chewed, divided, or dissolved. It is recommended to store at a temperature between 15°C to 30°C (59°F to 86°F) and in child-resistant containers. The medication guide is available at the website https://www.accordhealthcare.us/ and should be dispensed to each patient. This medication has been manufactured by Intas Pharmaceuticals Limited, India and is distributed by Accord Healthcare, Inc. in Durham, NC. Dosage information should be consulted in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
